Following ancestral TET2 mutations, individual disease course is determined by secondary hits: ASXL1, EZH2, and SF3B1 (splicing factor 3B subunit 1) secondary hits are common in MDS; DNMT3A and NPM1 secondary hits are common in AML [18]. Here, EZH2 is linked to acute myeloid leukemia.